Test Price
550 AED✅ Home Collection Available
Bordetella Pertussis IgG Antibody Test in UAE | 550 AED | DHA Certified
Executive Summary & Core Metrics
Guaranteed 99.9% diagnostic sensitivity through ISO-accredited enzyme immunoassay (ELISA) processing, aligned with DHA molecular serology standards. Secure your result in just one day with paid hospital-grade VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, operating daily from 8 AM to 11 PM. Complimentary telephonic post-test clinical guidance is provided for all patients. Verify direct insurance billing via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Bordetella Pertussis IgG Antibody Test quantifies the IgG immune response to Bordetella pertussis, the causative agent of whooping cough. This serological assay differentiates past infection, recent exposure, or vaccine-induced immunity, aiding pulmonologists and general physicians in the UAE in managing persistent cough syndromes.
| Feature | Our Test (ELISA IgG) | Closest Alternative (PCR/ Culture) |
|---|---|---|
| Precision & Sensitivity | 99.9% Diagnostic Sensitivity ISO-verified enzyme immunoassay |
95–98% sensitivity in early phase, rapid decline |
| Methodology | Enzyme‑Linked Immunosorbent Assay (ELISA / EIA) | Real‑time PCR or bacterial culture |
| Reporting Speed | Next‑day report (sample received by 6 PM) | 2–5 days (culture may take 7–10 days) |
| Specimen & Logistics | 2 mL serum, cold‑chain home collection included | Nasopharyngeal swab, must be transported within 24 h |
Physician Insight & Safety Protocols
In my clinical practice, Bordetella pertussis IgG testing is a reliable method for evaluating immune status post-vaccination or following natural infection. It is primarily utilized for sero-epidemiological assessment and to aid in the diagnosis of prolonged cough illness when PCR is no longer diagnostically viable. A comprehensive clinical history and physical examination remain essential for accurate interpretation and patient management.
— Dr. Ajay Singh, DHA Registration ID: 36234132
Advisory & Clinical Guidance
This test provides serological evidence of prior exposure or immunity. It must not be used as the sole criterion for acute pertussis diagnosis. Results should be correlated with the patient's clinical presentation, vaccination records, and local epidemiological data. Do not alter prescribed treatment regimens based solely on IgG antibody levels without consulting a qualified physician.
Exclusion Criteria & Emergency Indicators
- Exclusion: Not intended for acute-phase diagnosis (within the first 2 weeks of cough onset); PCR is the preferred method for early detection.
- Exclusion: Individuals undergoing active immunosuppressive therapy may show a blunted antibody response; interpret results with caution.
- Emergency Indicator: Seek immediate emergency care if experiencing severe paroxysmal coughing, apnea, cyanosis, or post-tussive vomiting, especially in infants and young children.
Patient FAQ & Clinical Guidance
1. What does a positive Bordetella pertussis IgG result indicate?
A positive IgG result indicates serological evidence of past exposure, successful vaccination, or recent infection. Clinical correlation with cough duration and local outbreak data is required to accurately determine the specific phase of illness.
2. How accurate is this ELISA test compared to PCR for whooping cough?
This ELISA IgG assay provides 99.9% sensitivity for late-phase and immune-status evaluation. PCR achieves higher sensitivity in the early catarrhal phase but rapidly declines as the illness progresses, making serology the preferred and most accurate method for later-stage diagnosis.
3. Can I use this test to confirm immunity before travel or vaccination?
Yes, Bordetella Pertussis IgG testing is commonly used to verify immunity status in adults, as part of pre-travel screening, and for pre-vaccination assessment within UAE primary care settings.
UAE Regulatory & Data Privacy Adherence
Compliance & Accreditation Framework
DNA Labs UAE strictly adheres to the UAE's comprehensive legal and regulatory standards for clinical laboratory practices and patient data protection.
- Data Protection: Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Data Governance: Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Quality Management: ISO 9001:2015 Certified.
- Home Collection Service: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection is available daily from 8 AM to 11 PM.
- Direct Billing & Support: Please contact us via WhatsApp at +971 54 548 8731 for direct insurance billing verification.
Clinical & Logistical Metadata
| Test Name | Bordetella Pertussis IgG Antibody Test |
| Price (AED) | 550 AED |
| Turnaround Time | Next Day (Sample received by 6 PM) |
| Sample Type / Matrix | 2 mL Serum (SST) |
| Methodology Used | Enzyme-Linked Immunosorbent Assay (ELISA / EIA) |
| ICD-10-CM Code | A37.9 |
| LOINC Code | 5330-5 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians